@article{90bf36b64669499ea0df8ca3dc705c74,
title = "Eruptive squamous cell carcinomas in metastatic melanoma: An unintended consequence of immunotherapy",
keywords = "Dynavax, SD-101, TLR9 agonist, checkpoint inhibitor therapy, eruptive squamous cell carcinomas, immune-related adverse events, matrix-metalloproteinase 13, metastatic melanoma, pembrolizumab",
author = "Samantha Haraszti and Samantha Polly and Ezaldein, {Harib H.} and Robert Rothbaum and Delost, {Gregory R.} and Mara Beveridge",
year = "2019",
month = jun,
doi = "10.1016/j.jdcr.2019.03.014",
language = "English (US)",
volume = "5",
pages = "514--517",
journal = "JAAD Case Reports",
issn = "2352-5126",
publisher = "Elsevier Inc.",
number = "6",
}